AI assistant
Biohit Oyj — Board/Management Information 2022
Jun 16, 2022
3304_rns_2022-06-16_aa236310-50b1-4817-9f94-377a8e49d46b.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Constitutive meeting of Biohit Oyj's Board of Directors
Biohit Oyj, Other information disclosed according to the rules of the Exchange, June 16, 2022 at 9:30 am local time (EEST)
Biohit Oyj's Board of Directors has in its meeting yesterday (June 15) elected PhD Lea Paloheimo as the Chairman of the Board of Directors.
Paloheimo has been Member of the Board of Directors of Biohit Oyj since 2019. She worked with Biohit Oyj in 2001-2019, for example as Production, Product Development and Quality Director, as well as Business Development Director.
Additional information: CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
[email protected] www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is "Innovating for Health" – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com